セッション詳細
[S5]Symposium 5 Next-Generation Vaccine Development
2026年9月3日(木) 10:10 〜 12:10
Lecture Hall(Auditorium)
Chair (s):Hisashi Arase(The Univ of Osaka)、Yasuo Yoshioka(The Univ of Osaka)
[S5-1]Modulating immunogenicity and reactogenicity in mRNA-lipid nanoparticle vaccines through lipid component optimization
○Yasuo Yoshioka1,2,3,4,5 (1. Research Institute for Microbial Diseases, The University of Osaka (Japan), 2. Institute for Open and Transdisciplinary Research Initiatives, The University of Osaka (Japan), 3. Center for Advanced Modalities and DDS, The University of Osaka (Japan), 4. Graduate School of Pharmaceutical Sciences, The University of Osaka (Japan), 5. The Research Foundation for Microbial Diseases of Osaka University (Japan))
[S5-3]Development of an Intranasal Therapeutic Vaccine for Cervical Cancer Leveraging the Mucosal Homing Pathway
○Rika Nakahashi1 (1. Chiba University Hospital, Human Mucosal Vaccinology (Japan))
[S5-4]Antibody-guided structure-based immunogens for vaccine-difficult pathogens like HIV-1
○Peter D. Kwong1 (1. ADARC, Columbia University (USA))
